ENSARTINIB

Clinical trials for ENSARTINIB explained in plain language.

Never miss a new study

Get alerted when new ENSARTINIB trials appear

Sign up with your email to follow new studies for ENSARTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New targeted pill may keep ALK lung cancer in check after standard treatment

Disease control Not yet recruiting

This study tests whether the targeted drug ensartinib can help people with ALK-mutated stage III lung cancer that cannot be removed by surgery. After completing standard chemoradiotherapy, 45 participants will receive either ensartinib or a placebo to see if the drug delays cance…

Matched conditions: ENSARTINIB

Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC

ENSARTINIB

Get alerted when new ENSARTINIB trials appear

New targeted pill may keep ALK lung cancer in check after standard treatment